Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

This study is testing how a drug called AZD5335 interacts with itraconazole (an antifungal medication) in women with ovarian, fallopian tube, or primary peritoneal cancer. The goal is to understand whether itraconazole changes how the body absorbs and processes AZD5335. **You may be eligible if...** - You have platinum-resistant high-grade ovarian, fallopian tube, or primary peritoneal cancer - You have had at least one prior platinum-based chemotherapy and your cancer progressed within 6 months of the last dose - You have previously received bevacizumab and/or a PARP inhibitor (if applicable based on guidelines) - Your general health is good (ECOG performance status 0 or 1) **You may NOT be eligible if...** - You have spinal cord compression or cancer in the fluid around the brain or spinal cord - You have unresolved side effects (grade 2 or higher) from prior treatment - You have a history of a non-drug-related lung disease Talk to your doctor to see if this trial is right for you.